|
Recent Developments |
|
28-DEC-10
Surya Pharmaceutical has acquired ActivOn, a leading OTC analgesic drug brand in the USA, with global marketing rights.The brand comes with the acquisition of Ameshire Investment Corp, USA through its 100% subsidiary based out of Singapore.
04-NOV-10
The company board has proposed and recommended sub-division of fully paid equity shares of Rs 10 each to fully paid equity shares of Re 1 each.
13-OCT-10
Surya Pharmaceutical announced... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 31-Mar-2013 (12) | 31-Mar-2012 (12) | 31-Mar-2011 (12) | | Net sales | 603.30 | 16229.50 | 15993.14 | | Other Income | -176.39 | -379.80 | 0.00 | | Total Income | 426.91 | 15849.70 | 15993.14 | | Cost of goods sold | 2173.15 | 17777.20 | 13515.10 | | OPBDIT | -1746.24 | -1927.50 | 2478.04 | | PAT | -3145.18 | -2725.00 | 1049.03 | | Gross Block | - | - | - | | Equity capital | 202.75 | 0.00 | 192.75 | | EPS (Rs.) | -15.51 | -13.44 | 6.44 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | NA | NA | 2.97 - 55.26 | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | -409.0 | -12.2 | 15.5 | | Net margin (% of OI) | -736.7 | -17.2 | 6.6 |
|
|
Detailed Financials
|
|
|
|
|
